0 NASDAQ Companies - February 25, 2019CRISPR Therapeutics and Vertex Announce Progress in Clinical Development Programs for the Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001Read More
0 NASDAQ Companies - February 25, 2019CEO of TRHC’s New Research & Development Institute to Present at National University of SingaporeRead More
0 NASDAQ Companies - February 25, 2019NanoVibronix Announces Publication of PainShield™ Trigeminal Neuralgia Study in the Journal of Anesthesiology and Pain ResearchRead More
0 NASDAQ Companies - February 25, 2019Multi-Color Corporation Enters Into Definitive Agreement to Be Acquired by an Affiliate of Platinum EquityRead More
0 NASDAQ Companies - February 25, 2019Galectin Therapeutics to Present at Berenberg NASH Day in New YorkRead More
0 NASDAQ Companies - February 25, 2019Chanticleer Holdings Management Team Issues Letter to ShareholdersRead More
0 NASDAQ Companies - February 25, 2019VBI Vaccines Provides Corporate Update, Outlook for 2019, and Year-End 2018 Financial ResultsRead More
0 NASDAQ Companies - February 25, 2019Finisar Experts to Speak at 2019 OFC Conference and OIDA Executive ForumRead More
0 NASDAQ Companies - February 25, 2019SMTC Corporation to Announce Fourth Quarter and Fiscal Year 2018 Results on March 14, 2019Read More
0 NASDAQ Companies - February 25, 2019Hoth Therapeutics Inc. Announces the Addition of Dr. Adam Friedman, M.D. to the Company's Scientific Advisory BoardRead More
